Cover Image
市場調查報告書

醫藥品的南美市場展望:2015-2025年

Latin American Pharmaceutical Market Outlook 2015-2025

出版商 Visiongain Ltd 商品編碼 339861
出版日期 內容資訊 英文 140 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
醫藥品的南美市場展望:2015-2025年 Latin American Pharmaceutical Market Outlook 2015-2025
出版日期: 2015年09月21日 內容資訊: 英文 140 Pages
簡介

南美的醫藥品市場收益,預計2018年達到872億9,000萬美元,到2025年穩定收益成長。

本報告提供南美的醫藥品市場相關調查、南美市場收益的預測、主要國家市場收益預測、南美整體經濟狀況、市場促進成長要素與阻礙要素,及南美的醫藥品的前五名公司相關分析。

第1章 報告概要

第2章 南美的醫藥品市場:簡介

  • 全球醫藥品市場:簡介
  • 南美的醫藥品市場
  • 地區的貿易團體、政府間組織

第3章 南美的醫藥品市場

  • 南美的醫藥品市場預測
  • 南美的醫藥品市場影響因素
    • 人口增加、高齡化
    • 經濟狀況
    • TPP (環太平洋夥伴關係協定)
  • 南美的醫藥品市場分析
    • 學名藥市場預測
    • OTC市場預測
    • 生技仿製藥市場預測
    • 首發醫藥品市場預測
  • 南美的醫藥品市場SWOT分析
    • 優勢
    • 弱點
    • 機會
    • 威脅

第4章 南美的主要國家市場

  • 南美的主要國家市場
  • 南美的主要國家的醫藥品市場
  • 南美的醫藥品市場上主要國家的市場佔有率

第5章 巴西的醫藥品市場

  • 醫藥品市場
  • 醫藥品次市場
    • 學名藥市場預測
    • OTC市場預測
    • 生技仿製藥市場預測
    • 首發醫藥品市場預測
  • 醫藥品次市場預測

第6章 墨西哥的醫藥品市場

第7章 委內瑞拉的醫藥品市場

第8章 阿根廷的醫藥品市場

第9章 哥倫比亞的醫藥品市場

第10章 智利的醫藥品市場

第11章 南美的其他的醫藥品市場

第12章 南美的醫藥品的前五名公司

  • Sanofi S.A
  • EMS S.A
  • Novarits
  • Pfizer
  • Bayer

第13章 結論

圖表

目錄
Product Code: PHA0066

What can be expected from the Latin American pharmaceutical market? Which areas are going to grow at the fastest rates? Visiongain's brand new report shows you potential revenues to 2025, assessing data, trends, opportunities and prospects there.

Our 140-page report provides 121 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. You will see financial results, interviews, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.

Forecasts from 2015-2025 and other analyses show you commercial prospects

Besides revenue forecasting to 2025, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.

image1

See revenue forecasts for the leading international markets

How will leading national markets perform to 2025? Our study forecasts revenues in national markets including by product class for the following countries:

  • Brazil
  • Mexico
  • Venezuela
  • Argentina
  • Colombia
  • Chile

Leading companies and potential for market growth

Overall revenue for the Latin American pharmaceutical market will reach $87.29bn in 2018, our work forecasts. We predict strong revenue growth through to 2025. The ageing population in many of the region's largest markets will combine with increasing investment in national health care systems to drive sales to 2025.

Our work analyses the key companies in the market. See visiongain's analysis of 5 leading companies, including these:

  • Sanofi
  • EMS
  • Novartis
  • Pfizer
  • Bayer

A company profile gives you the following information where available:

  • Historical revenues from 2013 to 2014
  • Discussion of a company's activities and outlook
  • Brief assessment of the companies Latin American strategy

Discover capabilities, progress, and commercial prospects, helping you stay ahead.

image2

image3

What issues will affect the Latin American pharmaceutical industry?

Our new report discusses issues and events affecting the Latin American pharmaceutical market. You will find discussions, including qualitative analyses:

  • Highly diverse region needing strong knowledge of each national market
  • Quickly evolving regulatory environment
  • Economic weaknesses encouraging innovation

You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.

How the Latin American Pharmaceutical Market Outlook 2015-2025 report helps you

In summary, our 140-page report gives you the following knowledge:

  • Revenue forecasts to 2025 for the Latin American pharmaceutical market - discover the industry's prospects, finding promising places for investments and revenues
  • Revenue forecasts to 2025 for the leading regional markets - Brazil, Mexico, Venezuela, Argentina, Colombia, Chile
  • Economic situation across the nations of Latin America - Understand the pressures faced across the region and how to achieve growth in an increasingly challenging environment
  • Assessment of 5 leading companies - analysis of Latin American results and strategies
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market

You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Latin American Pharmaceutical market and leading companies. You find data, trends and predictions. Please order our report now.

Table of Contents

1. Report Overview

  • 1.1 Latin American Pharmaceutical Market: Overview
  • 1.2 Latin American Pharmaceutical Market Segmentation
  • 1.3 Why You Should Read This Report
  • 1.4 How This Report Delivers
  • 1.5 Main Questions Answered by This Study
  • 1.6 Who is This Investigation For?
  • 1.7 Research and Analysis Methods
  • 1.8 Frequently Asked Questions (FAQs)
  • 1.9 Some Associated Reports
  • 1.10 About visiongain

2. Introduction to the Latin American Pharmaceutical Market

  • 2.1 Introduction to the Global Pharmaceutical Market
  • 2.2 The Latin American Pharmaceutical Market 2014
    • 2.2.1 Definition of Latin America
  • 2.3 Regional Trade Bodies and Intergovernmental Organisations
    • 2.3.1 Mercado Comun del Sur/Mercado Comum do Sul (Mercosur)
    • 2.3.2 The Andean Community (CAN)
    • 2.3.3 The Union of South American Nations (USAN)
    • 2.3.4 The Pacific Alliance
    • 2.3.5 Bolivarian Alliance for the Peoples of Our America (ALBA)

3. The Latin American Pharmaceutical Market, 2015-2025

  • 3.1 The Latin American Pharmaceutical Market Forecast, 2015-2025
  • 3.2 Factors Affecting the Latin American Pharmaceutical Market
    • 3.2.1 Population Growth and Ageing
    • 3.2.2 Economic Conditions
    • 3.2.3 Trans-Pacific Partnership (TPP)
  • 3.3 The Latin American Pharmaceutical Market Breakdown, 2015-2025
    • 3.3.1 The Latin American Generic Drugs Market Forecast, 2015-2025
    • 3.3.2 The Latin American OTC Market Forecast, 2015-2025
    • 3.3.3 The Latin American Biosimilars Market Forecast, 2015-2025
    • 3.3.4 The Latin American Originator Drugs Market Forecast, 2015-2025
  • 3.4 SWOT Analysis of the Latin American Pharmaceutical Market, 2015-2025
    • 3.4.1 Strengths
      • 3.4.1.1 One of the Quickest Growing Markets Globally
      • 3.4.1.2 Increasing Incidence of Chronic Diseases
      • 3.4.1.3 Ageing Population
      • 3.4.1.4 Increasing Investment in Health Care Systems
    • 3.4.2 Weaknesses
      • 3.4.2.1 Poor Economic Performance and Devalued Currencies
      • 3.4.2.2 Weak Regulation
      • 3.4.2.3 Weak IP Protection
    • 3.4.3 Opportunities
      • 3.4.3.1 Emerging Biosimilars Market
      • 3.4.3.2 Regional Pharmaceutical Companies Could Expand Outside Latin America
      • 3.4.3.3 Increased Trade Liberalisation Could Open More Markets
    • 3.4.4 Threats
      • 3.4.4.1 Pharmaceutical Companies from Other Emerging Markets Could Challenge Regional Firms
      • 3.4.4.2 Increased Protectionist Measures Could Severely Harm the Industry
      • 3.4.4.3 Further Economic Problems and Currency Devaluations Possible

4. Latin American National Markets, 2015-2025

  • 4.1 Latin American National Markets, 2014
  • 4.2 Latin American National Pharmaceutical Market Forecasts, 2015-2025
  • 4.3 Leading National Markets as Shares of the Latin American Pharmaceutical Market
    • 4.3.1 Leading National Markets as Shares of the Latin American Pharmaceutical Market, 2014
    • 4.3.2 Leading National Markets as Shares of the Latin American Pharmaceutical Market, 2020
    • 4.3.3 Leading National Markets as Shares of the Latin American Pharmaceutical Market, 2025

5. The Brazilian National Pharmaceutical Market, 2015-2025

  • 5.1 The Brazilian National Pharmaceutical Market, 2014
  • 5.2 The Brazilian National Pharmaceutical Sub-Market Forecasts, 2015-2025
    • 5.2.1 The Brazilian National Pharmaceutical Market Forecast, 2015-2025
    • 5.2.2 The Brazilian Generic Drugs Market Forecast, 2015-2025
    • 5.2.3 The Brazilian OTC Market Forecast, 2015-2025
    • 5.2.4 The Brazilian Biosimilars Market Forecast, 2015-2025
    • 5.2.5 The Brazilian Originator Drugs Market Forecast, 2015-2025
  • 5.3 The Brazilian National Pharmaceutical Sub-Market Forecasts Accounting for Current Currency Fluctuations

6. The Mexican National Pharmaceutical Market, 2015-2025

  • 6.1 The Mexican National Pharmaceutical Market, 2014
  • 6.2 The Mexican National Pharmaceutical Sub-Markets Forecasts, 2015-2025
    • 6.2.1 The Mexican National Pharmaceutical Market Forecast, 2015-2025
    • 6.2.2 The Mexican Generic Drugs Market Forecast, 2015-2025
    • 6.2.3 The Mexican OTC Market Forecast, 2015-2025
    • 6.2.4 The Mexican Biosimilars Market Forecast, 2015-2025
    • 6.2.5 The Mexican Originator Drugs Market Forecast, 2015-2025
  • 6.3 The Mexican National Pharmaceutical Sub-Market Forecasts Accounting for Current Currency Fluctuations

7. The Venezuelan National Pharmaceutical Market, 2015-2025

  • 7.1 The Venezuelan National Pharmaceutical Market, 2014
  • 7.2 The Venezuelan National Pharmaceutical Market Breakdown Forecast, 2015-2025
    • 7.2.1 The Venezuelan National Pharmaceutical Market Forecast, 2015-2025
    • 7.2.2 The Venezuelan Generic Drugs Market Forecast, 2015-2025
    • 7.2.3 The Venezuelan OTC Market Forecast, 2015-2025
    • 7.2.4 The Venezuelan Biosimilars Market Forecast, 2015-2025
    • 7.2.5 The Venezuelan Originator Drugs Market Forecast, 2015-2025
  • 7.3 The Venezuelan National Pharmaceutical Sub-Market Forecasts Accounting for Current Currency Fluctuations

8. The Argentine National Pharmaceutical Market, 2015-2025

  • 8.1 The Argentine National Pharmaceutical Market, 2014
  • 8.2 The Argentine National Pharmaceutical Market Breakdown, 2015-2025
    • 8.2.1 The Argentine National Pharmaceutical Market Forecast, 2015-2025
    • 8.2.2 The Argentine Generic Drugs Market Forecast, 2015-2025
    • 8.2.3 The Argentine OTC Market Forecast, 2015-2025
    • 8.2.4 The Argentine Biosimilars Market Forecast, 2015-2025
    • 8.2.5 The Argentine Originator Drugs Market Forecast, 2015-2025
  • 8.3 The Argentine National Pharmaceutical Sub-Market Forecasts Accounting for Current Currency Fluctuations

9. The Colombian National Pharmaceutical Market, 2015-2025

  • 9.1 The Colombian National Pharmaceutical Market, 2014
  • 9.2 The Colombian National Pharmaceutical Market Breakdown, 2015-2025
    • 9.2.1 The Colombian National Pharmaceutical Market Forecast, 2015-2025
      • 9.2.1.1 Economic Growth and Financial Constraints
      • 9.2.1.2 Introduction of the Statutory Health Law
    • 9.2.2 The Colombian Generic Drugs Market Forecast, 2015-2025
    • 9.2.3 The Colombian OTC Market Forecast, 2015-2025
    • 9.2.4 The Colombian Biosimilars Market Forecast, 2015-2025
    • 9.2.5 The Colombian Originator Drugs Market Forecast, 2015-2025
  • 9.3 The Colombian National Pharmaceutical Sub-Market Forecasts Accounting for Current Currency Fluctuations

10. The Chilean National Pharmaceutical Market, 2015-2025

  • 10.1 The Chilean National Pharmaceutical Market, 2014
    • 10.1.1 The Chilean Health Care System
    • 10.1.2 Majority of Generic Revenue from Branded Generics
  • 10.2 The Chilean National Pharmaceutical Market Breakdown, 2015-2025
    • 10.2.1 The Chilean National Pharmaceutical Market Forecast, 2015-2025
    • 10.2.2 The Chilean Generic Drugs Market Forecast, 2015-2025
    • 10.2.3 The Chilean OTC Market Forecast, 2015-2025
    • 10.2.4 The Chilean Biosimilars Market Forecast, 2015-2025
    • 10.2.5 The Chilean Originator Drugs Market Forecast, 2015-2025
  • 10.3 The Chilean National Pharmaceutical Sub-Market Forecasts Accounting for Current Currency Fluctuations

11. The Rest of the Latin American Pharmaceutical Market, 2015-2025

  • 11.1 The Rest of the Latin American Pharmaceutical Market, 2014
  • 11.2 The Rest of the Latin American Pharmaceutical Market Breakdown, 2015-2025
    • 11.2.1 The Rest of the Latin American Pharmaceutical Market Forecast, 2015-2025
    • 11.2.2 The Rest of the Latin American Generic Drugs Market Forecast, 2015-2025
    • 11.2.3 The Rest of the Latin American OTC Market Forecast, 2015-2025
    • 11.2.4 The Rest of the Latin American Biosimilars Market Forecast, 2015-2025
    • 11.2.5 The Rest of the Latin American Originator Drugs Market Forecast, 2015-2025
  • 11.3 Accounting for Currency Fluctuations in the Rest of Latin America

12. Top Five Pharmaceutical Companies in Latin America

  • 12.1 Sanofi S.A
  • 12.2 EMS S.A
  • 12.3 Novarits
  • 12.4 Pfizer
  • 12.5 Bayer

13. Conclusions

  • 13.1 The Latin American Pharmaceutical Market, 2014-2025
  • 13.2 Latin American Pharmaceutical Market Forecast, 2015-2025

List of Tables

  • Table 2.1 Market Share (%) of the Global Pharmaceutical Market by Region, 2014
  • Table 2.2 Population Sizes of Latin American Countries/Regions and Percentage of Total Population (%), 2012
  • Table 3.1 The Latin American Pharmaceutical Market: Revenue ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 3.2 Percentage (%) of Population Over 65 Years Old in Key Latin American Markets, plus Average, 2010 and 2050
  • Table 3.3 The Latin American Pharmaceutical Market Breakdown, Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 3.4 The Latin American Generic Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 3.5 The Latin American OTC Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025 Table 3.6 The Latin American Biosimilars Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 3.7 The Latin American Originator Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 3.8 SWOT Analysis of the Latin American Pharmaceutical Market, 2014-2025
  • Table 4.1 Market Revenues ($bn) of the Six Largest Pharmaceutical Markets in Latin America, 2014
  • Table 4.2 The Latin American National Pharmaceutical Markets: Revenue ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 4.3 National Market Revenues ($bn) and Latin American Market Shares (%), 2014
  • Table 4.4 National Market Revenues ($bn) and Latin American Market Shares (%), 2020
  • Table 4.5 National Market Revenues ($bn) and Latin American Market Shares (%), 2025
  • Table 5.1 Brazilian National Market Breakdown: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 5.2 Brazilian National Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 5.3 Brazilian Generic Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 5.4 Brazilian OTC Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 5.5 Brazilian Biosimilars Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 5.6 Brazilian Originator Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 5.7 Brazilian National Market Breakdown: Revenue (Currency Adjusted) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 6.1 Mexican National Market Breakdown: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 6.2 Mexican National Pharmaceutical Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 6.3 Mexican Generic Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 6.4 Mexican OTC Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 6.5 Mexican Biosimilars Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 6.6 Mexican Originator Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 6.7 Mexican National Market Breakdown: Revenue (Currency Adjusted) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 7.1 Venezuelan National Market Breakdown: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 7.2 Venezuelan National Pharmaceutical Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 7.3 Venezuelan Generic Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 7.4 Venezuelan OTC Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 7.5 Venezuelan Biosimilars Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 7.6 Venezuelan Originator Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 8.1 Argentine National Market Breakdown: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 8.2 Argentine National Pharmaceutical Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 8.3 Argentine Generic Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 8.4 Argentine OTC Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 8.5 Argentine Biosimilars Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 8.6 Argentine Originator Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 8.7 Argentine National Market Breakdown: Revenue (Currency Adjusted) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 9.1 Colombian National Market Breakdown: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 9.2 Colombian National Pharmaceutical Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 9.3 Colombian Generic Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 9.4 Colombian OTC Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 9.5 Colombian Biosimilars Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 9.6 Colombian Originator Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 9.7 Colombian National Market Breakdown: Revenue (Currency Adjusted) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 10.1 Branded Market Share (%) of Generic Drugs Market by Value, 2014
  • Table 10.2 Chilean National Market Breakdown: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 10.3 Chilean National Pharmaceutical Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 10.4 Chilean Generic Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 10.5 Chilean OTC Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 10.6 Chilean Biosimilars Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 10.7 Chilean Originator Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 10.8 Chilean National Market Breakdown: Revenue (Currency Adjusted) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 11.1 The Rest of the Latin American Pharmaceutical Market Breakdown: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 11.2 Rest of the Latin American Pharmaceutical Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 11.3 Rest of the Latin American Generic Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 11.4 Rest of the Latin American OTC Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 11.5 Rest of the Latin American Biosimilars Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 11.6 Rest of the Latin American Originator Drugs Market: Revenue (Constant Currencies) ($bn), AGR (%) and CAGR (%), 2014-2025
  • Table 12.1 Sanofi S.A Total Revenue ($bn) and Latin American Revenue ($bn) and AGR (%), 2013-2014
  • Table 12.2 Novartis Total Revenue ($bn) and Latin American Revenue ($bn) and AGR (%), 2013-2014
  • Table 13.1 The Latin American National Pharmaceutical Markets: Revenue ($bn), AGR (%), 2014-2015
  • Table 13.2 The Latin American Pharmaceutical Market: Revenue ($bn), AGR (%), CAGR (%), 2014-2025

List of Figures

  • Figure 1.1 Population Sizes of Latin American Countries/Regions by Percentage (%), 2013
  • Figure 1.2 Key Markets within the Latin American Pharmaceutical Market
  • Figure 1.3 Key Product Types within the Latin American Pharmaceutical Market
  • Figure 2.1 Market Shares (%) of Pharmaceutical Market by Region, 2014
  • Figure 2.2 Population Sizes of Latin American Countries/Regions by Percentage (%), 2012
  • Figure 3.1The Latin American Pharmaceutical Market: Revenue ($bn) and AGR (%), 2014-2025
  • Figure 3.2 Population Pyramid for Latin America, 2010
  • Figure 3.3 Population Pyramid for Latin America, 2025
  • Figure 3.4 The Latin American Generic Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 3.5 The Latin American OTC Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 3.6 The Latin American Biosimilars Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 3.7 The Latin American Originator Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 4.1 Market Revenues ($bn) of Six Largest Pharmaceutical Markets in Latin America plus Rest of Latin America, 2014
  • Figure 4.2 Market Revenues ($bn) of Six Largest Pharmaceutical Markets in Latin America plus Rest of Latin America, 2014
  • Figure 4.3 Market Revenues ($bn) of Six Largest Pharmaceutical Markets in Latin America plus Rest of Latin America, 2020
  • Figure 4.4 Market Revenues ($bn) of Six Largest Pharmaceutical Markets in Latin America plus Rest of Latin America, 2025
  • Figure 5.1 Brazilian National Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 5.2 Brazilian Generic Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 5.3 Brazilian OTC Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 5.4 Brazilian Biosimilars Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 5.5 Brazilian Originator Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 6.1 Mexican National Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 6.2 Mexican Generic Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 6.3 Mexican OTC Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 6.4 Mexican Biosimilars Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 6.5 Mexican Originator Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 7.1 Venezuelan National Pharmaceutical Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 7.2 Venezuelan Generic Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 7.3 Venezuelan OTC Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 7.4 Venezuelan Biosimilars Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 7.5 Venezuelan Originator Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 8.1 Argentine National Pharmaceutical Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 8.2 Argentine Generic Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 8.3 Argentine OTC Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 8.4 Argentine Biosimilars Market: Revenue (Constant Currencies) $bn) and AGR (%), 2014-2025
  • Figure 8.5 Argentine Originator Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 9.1 Colombian National Pharmaceutical Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 9.2 Colombian Generic Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 9.3 Colombian OTC Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 9.4 Colombian Biosimilars Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 9.5 Colombian Originator Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 10.1 Branded Market Share (%) of Generic Drugs Market by Value, 2014
  • Figure 10.2 Chilean National Pharmaceutical Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 10.3 Chilean Generic Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 10.4 Chilean OTC Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 10.5 Chilean Biosimilars Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 10.6 Chilean Originator Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 11.1 Rest of the Latin American National Pharmaceutical Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 11.2 Rest of the Latin American Generic Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 11.3 Rest of the Latin American OTC Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 11.4 Rest of the Latin American Biosimilars Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 11.5 Rest of the Latin American Originator Drugs Market: Revenue (Constant Currencies) ($bn) and AGR (%), 2014-2025
  • Figure 13.1 The Latin American National Pharmaceutical Markets: Revenue ($bn), 2014-2015
  • Figure 13.2 The Latin American Pharmaceutical Market: Revenue ($bn), 2014-2025

Companies Listed

  • Abbott Laboratories
  • Aspen Pharmaceuticals
  • Bago
  • Bayer AG
  • Bioceres
  • Biocon
  • Celltrion
  • CFR Pharmaceuticals
  • EMS S.A
  • Genfar
  • Germed
  • GlaxoSmithKline
  • Hospira
  • Janssen RA
  • Laboratorio Teuto Brasileiro.
  • Laboratorios Bernabo
  • Laboratorios Kendrick
  • LaFrancol
  • LeGrand
  • Medley
  • Merck AG
  • Novartis
  • Orygen
  • Pemex
  • Pfizer
  • Priobiomed
  • Roemmers
  • Sandoz
  • Sanofi S.A
  • Shanghai CP Goujian
  • Takeda

Other Organisations Mentioned In The Report

  • Bolivarian Alliance for the Peoples of Our America (ALBA)
  • Brazilian Ministry of Health
  • Brazilian Unified Health System
  • Chilean Institute of Public Health
  • COFEPRIS
  • Instituto de Seguridad y Servicios Sociales de los Trabajadoes del Estad (ISSSTE)
  • Instituto Mexicano del Seguro Social (IMSS)
  • Instituto Venezolano de los Seguros Sociales (IVSS)
  • Mercosur
  • National Drugs Agency (ANAMED)
  • Pan American Health Organisation
  • Sistema General de Seguridad Social en Salud
  • The Andean Community (CAN)
  • The Pacific Alliance
  • The Union of South American Nations (USAN)
  • Trans-Pacific Partnership
  • United Nations Department of Economic and Social Affairs
  • Venezuelan Ministry of Popular Power for Health
Back to Top